Stopped: Because funding was not secured, the study was never initiated. 0 subjects enrolled
The investigators will assess changes in breast appearance, graft retention and quality of life over one year in patients who have received direct autologous adipose tissue injection for the treatment of objectionable post-surgical breast deformities. These patients have undergone the resection of breast tissue to treat either benign or malignant breast disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Breast Tissue Volume/Appearance (Graft Retention)
Timeframe: Through 12 months following procedure